Jeffrey S. Weber, MD, PhD: This has been extremely informative. But before we end this discussion, I’d like to get some final thoughts from each of the panelists. Dr Jason Luke?
Archive | Video Reports
The Role of BRAF Mutations in Melanoma
My name is Adil Daud. I’m a medical oncologist. I work at the University of California, San Francisco, where I direct melanoma research and the melanoma program.
Posted in Melanoma News, Health Professionals, Video Reports
Management of Patients with BRAF-Mutated Melanoma
My personal approach to sequencing treatments in BRAF-mutant patients is to look at all the different factors that are involved.
Posted in Melanoma News, Health Professionals, Video Reports
Melanoma: Progression After Immunotherapy
Jeffrey S. Weber, MD, PhD: Let’s transition to the elephant in the room. We’ve heard great things about single-agent PD-1 [programmed cell death protein 1] blockade, ipilimumab-nivolumab, BRAF/MEK—multiple combinations, all frontline therapy.
Posted in Melanoma News, Health Professionals, Video Reports
